Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,23017,667,1.83 [1.43-2.34],1.7207358735004397e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,22811,659,1.33 [1.18-1.51],7.332455996138792e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",22811,659,1.39 [1.22-1.59],8.670414717074823e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19658,569,1.68 [1.43-1.97],1.814289445204034e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22811,659,1.73 [1.37-2.17],2.9918346639842065e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,20218,586,1.79 [1.42-2.27],1.229151708864363e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,19801,575,3.85 [3.17-4.68],1.342063721661144e-41
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,23432,678,1.99 [1.53-2.59],3.231594570407991e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",AFM,Afamin,20253,588,2.74 [1.79-4.18],3.1820959618058583e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,23336,679,2.11 [1.75-2.54],2.346182286158154e-15
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,23502,678,2.78 [1.97-3.91],4.835189303444266e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,19801,575,2.26 [1.89-2.69],8.634949986236992e-20
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,22913,663,1.88 [1.48-2.37],1.749499730002127e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,23268,678,1.64 [1.38-1.94],1.1402192570506134e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,23297,679,1.72 [1.48-2.00],2.614499205273659e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,23432,678,1.72 [1.44-2.05],1.458058996702104e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,23292,676,1.77 [1.41-2.22],8.031818235546055e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,20065,581,2.18 [1.73-2.76],6.420092065763494e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,20229,589,0.48 [0.36-0.63],1.963755526728829e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,23068,663,2.00 [1.71-2.33],1.5059474910410318e-18
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,20221,585,1.76 [1.38-2.25],4.707107328743694e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,23236,674,2.30 [1.75-3.01],1.7143876395825939e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,19801,575,2.15 [1.61-2.87],2.495927888748373e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,20184,582,1.44 [1.30-1.60],2.3660948880802442e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,23292,676,1.41 [1.21-1.65],8.320680105995631e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,19764,574,1.86 [1.43-2.42],3.432739645514714e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,23432,678,0.58 [0.48-0.71],1.0574521697451372e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19713,574,1.44 [1.28-1.62],3.1726651345480086e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,23502,678,1.54 [1.34-1.78],3.33542936902209e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,23032,662,1.51 [1.33-1.70],5.6443200103110435e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,23190,675,1.27 [1.15-1.40],2.240840235816143e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,23087,676,1.24 [1.13-1.36],7.0784843504245256e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,23469,678,1.89 [1.57-2.26],1.091870471037163e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,23292,676,1.59 [1.36-1.85],4.069097930168527e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,23302,679,0.61 [0.51-0.73],5.1375488674990496e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,23227,679,1.69 [1.39-2.05],1.449297370640384e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,23439,677,0.74 [0.65-0.84],2.862638172336913e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,19801,575,1.63 [1.36-1.97],2.3180280294643602e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,20221,585,1.78 [1.43-2.23],3.7034712659576987e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,23190,675,0.59 [0.47-0.73],2.882343584512936e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,22322,652,1.87 [1.50-2.31],1.3200736312185954e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,23068,663,1.54 [1.35-1.76],7.762263072944839e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,23502,678,2.04 [1.65-2.52],5.383918785004319e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,23227,673,1.55 [1.29-1.88],4.950724861795936e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,23269,679,1.84 [1.41-2.40],5.495652566650887e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,20121,584,1.33 [1.20-1.48],9.952745538514969e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19801,575,6.75 [5.32-8.58],5.178923490653659e-55
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,23371,677,1.72 [1.36-2.17],6.7528904980646695e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,23236,674,1.77 [1.43-2.18],1.08328180953277e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,23502,678,2.12 [1.64-2.75],1.1648985028906252e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,20121,584,1.54 [1.32-1.80],3.8609673935413686e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,23227,673,1.62 [1.37-1.92],1.1113644503555591e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,19801,575,2.10 [1.76-2.50],1.180470170899653e-16
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,23502,678,1.67 [1.38-2.01],7.499835300875274e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,23190,675,1.59 [1.40-1.81],9.425099780739661e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,23227,679,2.33 [1.80-3.01],1.0751011634392999e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,22925,669,1.83 [1.53-2.18],2.039821580447656e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,19801,575,1.82 [1.47-2.25],2.759129980002241e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,23336,679,2.17 [1.57-3.00],3.065472454661329e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,20044,584,0.50 [0.38-0.67],3.1118689194580613e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,23336,679,0.46 [0.35-0.59],4.135921657275585e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,23336,679,2.28 [1.80-2.88],7.140921453795865e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,19609,570,1.59 [1.30-1.94],5.275114081866727e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,22791,663,1.47 [1.29-1.68],9.275000450632957e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,20218,586,2.29 [1.80-2.91],1.0791885086857992e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,20218,586,2.20 [1.70-2.86],2.814361616365922e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,23480,678,2.24 [1.82-2.77],4.93369255359846e-14
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,23212,675,2.34 [1.89-2.90],5.22996635671402e-15
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,23068,663,1.73 [1.42-2.10],3.3547370850657767e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,23046,667,1.23 [1.13-1.34],1.3411697430500565e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,23227,673,1.91 [1.54-2.36],4.178715102705866e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,19801,575,2.22 [1.69-2.92],9.752398140535109e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,23502,678,2.26 [1.80-2.84],1.5111422004094942e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,19713,574,1.38 [1.20-1.59],9.8411358568322e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,22773,665,2.19 [1.74-2.77],4.3242513839907485e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,23502,678,2.82 [2.12-3.74],7.328431542019773e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,23129,678,2.13 [1.63-2.78],2.1939179158455e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,23432,678,2.15 [1.81-2.55],2.432627752302881e-18
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,23502,678,0.36 [0.23-0.54],1.097054425162787e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ELN,Elastin,20221,585,1.90 [1.53-2.36],6.4971797620230475e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,22791,663,1.37 [1.20-1.57],4.731901976248327e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,22411,661,1.68 [1.36-2.07],1.3125855006511425e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,23502,678,1.83 [1.40-2.39],8.050514516010476e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,23020,663,1.84 [1.48-2.30],6.313004257515315e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,23190,675,1.25 [1.15-1.35],1.81912349992428e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,23302,679,3.10 [2.34-4.12],3.909200802392567e-15
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,23164,676,2.30 [1.62-3.26],2.706393961070386e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,23292,673,1.74 [1.37-2.22],5.726320942124857e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",23502,678,1.55 [1.36-1.77],3.7362882357226016e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,20218,586,2.17 [1.70-2.76],3.1189195642024075e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,23236,674,1.74 [1.51-2.00],2.6304606510718395e-14
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,23370,675,0.56 [0.48-0.66],1.5812565182928253e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,23254,675,1.91 [1.53-2.37],6.307816009560168e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,23302,679,2.34 [1.72-3.17],4.8322898682713415e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,23480,678,4.00 [3.27-4.89],1.44258219462151e-41
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,20182,585,1.49 [1.25-1.77],9.90167854531544e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,23433,680,1.73 [1.37-2.17],2.963156406910968e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,23190,675,1.62 [1.32-2.00],6.429037230054686e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,23433,680,2.05 [1.77-2.37],1.8700986953838723e-21
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,23354,677,2.87 [2.20-3.74],6.1872842354340856e-15
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,23502,678,1.56 [1.38-1.77],3.305093949315587e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,23227,673,1.83 [1.52-2.21],3.4574356154072887e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,23392,677,2.00 [1.58-2.53],8.033067123771443e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,22821,667,1.57 [1.30-1.89],3.0255464580587475e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,23068,663,1.93 [1.45-2.57],6.234315644108396e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,23433,680,2.05 [1.55-2.73],6.901580891668807e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,23432,678,1.73 [1.37-2.19],4.6210792179173096e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,22600,659,2.13 [1.66-2.73],2.520451372809028e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,23336,674,1.56 [1.40-1.74],3.3387466922160096e-16
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,23236,674,1.60 [1.32-1.93],1.7256880646012085e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,19801,575,2.41 [1.78-3.26],1.429474061573179e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,22972,667,1.51 [1.31-1.74],9.776275436627248e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,23432,678,1.68 [1.40-2.02],1.853562804821376e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,23112,674,1.81 [1.44-2.27],4.481198897356833e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19621,565,1.91 [1.58-2.30],9.497726452551194e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,23336,679,2.16 [1.55-3.01],4.93126827056684e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,23462,677,0.77 [0.69-0.86],1.7186007259444878e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,23292,676,1.92 [1.48-2.49],1.1141807956787762e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,22932,665,1.56 [1.35-1.82],5.688663526722644e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,23227,673,1.70 [1.40-2.06],5.02136965980594e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,23129,678,1.65 [1.39-1.96],1.0937234939976593e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,23336,679,1.77 [1.42-2.20],4.228526209163461e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,22936,667,2.34 [1.68-3.25],4.999801142259156e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,23190,675,1.62 [1.33-1.98],1.640825467349776e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,23148,675,1.40 [1.23-1.60],5.855189747449658e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,23236,674,0.61 [0.52-0.72],6.150181266814608e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,23190,676,1.31 [1.17-1.46],1.1232996584153711e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,23190,675,0.74 [0.65-0.84],5.303628479517899e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,20109,578,1.45 [1.25-1.68],6.955118219354862e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,23190,675,1.76 [1.48-2.09],1.3827487564759369e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,23236,674,1.86 [1.42-2.44],7.581576872797142e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,20218,586,1.73 [1.41-2.13],1.861188275256765e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,23433,680,2.03 [1.58-2.60],2.6646899959472453e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,23432,678,1.54 [1.40-1.70],6.413118146315975e-18
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,19713,574,2.06 [1.56-2.72],3.248637453493133e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,23020,663,1.63 [1.35-1.98],6.172773087788559e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,23229,679,1.88 [1.54-2.31],8.22193156412541e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,23190,675,1.90 [1.46-2.48],1.5847481197118209e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,20182,585,2.38 [1.88-3.01],3.8876660483656293e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,23129,678,2.43 [1.91-3.09],4.341374063768841e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,23227,673,1.64 [1.35-1.98],3.323502783511584e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,19835,576,1.21 [1.12-1.29],2.0480126526376417e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,23502,678,2.38 [1.94-2.92],5.782999361734204e-17
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,23122,676,1.91 [1.51-2.41],6.755326440763908e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,23110,674,1.60 [1.32-1.93],1.2403105400373145e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,20253,588,3.06 [2.06-4.54],2.6763199683289723e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,19510,565,2.25 [1.92-2.62],1.9060967114798412e-24
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,20221,585,2.40 [1.93-2.98],2.05378891281723e-15
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,23292,676,1.64 [1.35-1.99],6.975347184781272e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,23068,663,1.26 [1.14-1.40],8.688577212145164e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,23434,678,3.91 [2.86-5.36],1.76999215525852e-17
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,20221,585,1.99 [1.52-2.60],5.220874780418157e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,23227,679,0.55 [0.43-0.69],4.296895082892306e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,23285,674,2.98 [2.13-4.19],2.613179723699625e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,19801,575,1.79 [1.39-2.31],6.283445699408767e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,23502,678,0.64 [0.54-0.76],1.0289618022379673e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,22655,661,1.72 [1.40-2.13],4.250081927977618e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,23236,674,0.67 [0.57-0.77],1.5779067265167754e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,20229,589,1.96 [1.50-2.56],6.797512445875072e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,23433,680,1.62 [1.40-1.89],4.21983167293419e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,22960,660,1.32 [1.18-1.48],1.5804149885093005e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,20121,584,1.72 [1.37-2.17],3.198416689744029e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,23192,672,1.70 [1.35-2.14],6.009768122984917e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,22574,659,1.58 [1.35-1.84],6.3240126642427324e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,23480,678,2.12 [1.67-2.70],1.0394249435820488e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,23236,674,1.98 [1.50-2.61],1.1984949650063969e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,20221,585,1.76 [1.50-2.08],1.7276209683832975e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,22811,659,1.15 [1.08-1.21],1.4726075150239091e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,23190,675,1.50 [1.29-1.75],1.76119421539987e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,23336,677,2.05 [1.62-2.60],3.462350926817156e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,23236,674,2.39 [1.93-2.96],1.276863844961032e-15
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,20182,585,1.72 [1.42-2.08],2.95253520291292e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,23227,673,1.18 [1.11-1.27],5.166608191734595e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,23236,674,1.64 [1.39-1.93],2.3118229210269627e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,23336,679,1.75 [1.48-2.06],3.7624923100692496e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,23068,663,0.86 [0.80-0.92],5.788378953651259e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,20182,585,1.88 [1.56-2.26],3.615229148868048e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,23227,673,1.84 [1.53-2.23],2.2012894728873847e-10
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,23227,673,1.95 [1.55-2.45],1.3186561852327633e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,23480,678,2.12 [1.73-2.59],6.012048559260055e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19987,580,2.20 [1.69-2.87],4.900040113225255e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,23398,675,1.91 [1.44-2.55],8.647724346278788e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,20218,586,1.58 [1.30-1.92],4.154118253963432e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,23363,671,1.72 [1.41-2.10],1.19508406291657e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,20182,585,1.50 [1.31-1.73],9.729580670533688e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,23151,673,2.01 [1.52-2.66],9.968625978241477e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,20221,585,1.99 [1.57-2.53],1.6046376768667776e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,22557,653,1.35 [1.21-1.52],3.33000245100986e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,23190,675,1.44 [1.24-1.69],3.6371737048931615e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,23433,680,1.52 [1.27-1.82],3.4057584170686303e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,20190,584,1.77 [1.49-2.09],3.2837920045102806e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,23129,678,1.72 [1.46-2.03],8.694012113629959e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,23269,679,2.50 [1.93-3.25],4.391251816087785e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,23433,680,3.05 [2.30-4.05],1.0301388054863321e-14
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,23227,673,1.78 [1.43-2.21],2.332893363797595e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,22634,651,1.90 [1.53-2.35],3.873086578302889e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,23433,680,1.84 [1.46-2.32],3.130450327177135e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,20221,585,2.61 [2.02-3.36],1.3137067410879214e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,23227,673,1.75 [1.51-2.03],1.897119510762935e-13
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,20140,584,1.82 [1.46-2.25],5.754313965037871e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,23502,678,1.64 [1.38-1.95],2.1923256247433143e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,22569,658,1.16 [1.10-1.23],3.1519011659257674e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,20168,583,3.23 [1.99-5.24],2.082856780770783e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,19941,580,1.62 [1.32-1.99],3.4844911127885536e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,20253,588,8.69 [5.99-12.60],4.3260749047706925e-30
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,23000,661,1.43 [1.23-1.66],3.438778231866149e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,23336,679,1.58 [1.35-1.84],6.9173442205080306e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,22791,663,0.68 [0.60-0.78],8.678806791620258e-09
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,23020,663,0.71 [0.65-0.79],1.5339720689917097e-11
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,23172,674,1.92 [1.50-2.46],2.254105328665919e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,23269,679,2.43 [2.00-2.94],1.6801749564655984e-19
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,23462,677,1.97 [1.71-2.27],1.2603452108349136e-20
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,23433,680,1.50 [1.28-1.75],3.422290404178521e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,23203,674,0.44 [0.35-0.55],2.038956152772141e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,23190,675,1.31 [1.18-1.46],5.819709055115956e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,19679,569,1.75 [1.38-2.23],4.698140162737339e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,23029,663,1.36 [1.27-1.46],6.096068099556196e-17
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,23297,679,1.47 [1.32-1.64],4.87542602593711e-12
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,23183,671,1.37 [1.23-1.53],1.2591024653868721e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,23236,674,1.55 [1.31-1.84],5.593812930645571e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,22959,662,1.64 [1.36-1.98],2.792722787492029e-07
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,23292,676,1.46 [1.27-1.68],8.98231525922717e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,23269,679,0.38 [0.30-0.48],1.3733809287262106e-16
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,23463,678,2.44 [1.97-3.02],2.980981259526127e-16
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,20109,578,1.33 [1.18-1.51],6.062367926617108e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,22984,662,1.64 [1.37-1.95],5.6658918906136615e-08
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,23432,678,1.56 [1.28-1.89],9.967666668616692e-06
Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,20182,585,2.23 [1.72-2.91],2.3487298625191358e-09
